Cargando…
Current and emerging therapies for first line treatment of metastatic clear cell renal cell carcinoma
The therapeutic landscape for advanced clear cell renal cell carcinoma (ccRCC) is rapidly evolving with improved knowledge of the biology of disease leading to the incorporation of a variety of antiangiogenic agents and immunotherapies. In this review, we discuss historical, current, and emerging fi...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923624/ https://www.ncbi.nlm.nih.gov/pubmed/35295921 http://dx.doi.org/10.20517/2394-4722.2021.76 |